English | Español

Technology/Innovation
+ Technology/Innovation
Nicholas Gueguen | Jul 23, 2017

Bristol-Myers Squibb, Pfizer say analysis indicates lower risk of stroke, major bleeding using Eliquis vs. warfarin
+ Regulatory
Nicholas Gueguen | Jul 23, 2017

Novartis says its Entresto better than enalapril in managing blood sugar levels of diabetics who had heart failure
+ Regulatory
Nicholas Gueguen | Jul 23, 2017

GlaxoSmithKline study to test mepolizumab for fighting severe hypereosinophilic syndrome
+ Technology/Innovation
Nicholas Gueguen | Jul 23, 2017

Incyte, Merck to conduct tests on epacadostat and Keytruda combination treatment
+ Technology/Innovation
Nicholas Gueguen | Jul 23, 2017

Study: Dupixent used with topical corticosteroids improves atopic dermatitis
+ Technology/Innovation
Nicholas Gueguen | Jul 23, 2017

DelMar gives glioblastoma patients investigational drug in Phase 2 trial
+ Technology/Innovation
Nicholas Gueguen | Jul 22, 2017

Opdivo-Yervoy combination boosts overall survival in advanced melanoma patients
+ Technology/Innovation
Nicholas Gueguen | Jul 22, 2017

ORION-1 Phase II data shows promise for inclisiran

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns